調査レポート | • レポートコード：GIR-2104Z03997 • 出版社/出版日：GlobalInfoResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、106ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療 |
| Single User | ￥494,160 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥741,240 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥988,320 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、クローン病治療のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。クローン病治療の種類別市場規模（非手術的、手術的）、用途別市場規模（病院、外来手術センター）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・クローン病治療の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Johnson and Johnson Services Inc.、Pfizer Inc.、Allergan、AbbVie Inc.、Takeda Pharmaceutical Company Limited、Celgene Corporation、Perrigo Company PLC、Ferring B.V.、Salix Pharmaceuticals、Gilead Sciences Inc.、Genentech Inc.、UCB India Private Limited. ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：非手術的、手術的 ・用途別分析2016年-2026年：病院、外来手術センター ・クローン病治療の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・クローン病治療のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・クローン病治療のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・クローン病治療の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・クローン病治療の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Crohn’s Disease Therapeutics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Crohn’s Disease Therapeutics size is estimated to be USD 3655.4 million in 2025 from USD 3471 million in 2019, with a change XX% between 2019 and 2020. The global Crohn’s Disease Therapeutics market size is expected to grow at a CAGR of 1.3% for the next five years.
Market segmentation
Crohn’s Disease Therapeutics market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Non-Surgical
Surgical
Market segment by Application, can be divided into
Hospitals
Ambulatory Surgical Centers
Market segment by players, this report covers
Johnson and Johnson Services Inc.
Pfizer Inc.
Allergan
AbbVie Inc.
Takeda Pharmaceutical Company Limited
Celgene Corporation
Perrigo Company PLC
Ferring B.V.
Salix Pharmaceuticals
Gilead Sciences Inc.
Genentech Inc.
UCB India Private Limited.
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
1 Market Overview
1.1 Product Overview and Scope of Crohn’s Disease Therapeutics
1.2 Classification of Crohn’s Disease Therapeutics by Type
1.2.1 Overview: Global Crohn’s Disease Therapeutics Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Crohn’s Disease Therapeutics Revenue Market Share by Type in 2020
1.2.3 Non-Surgical
1.2.4 Surgical
1.3 Global Crohn’s Disease Therapeutics Market by Application
1.3.1 Overview: Global Crohn’s Disease Therapeutics Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Hospitals
1.3.3 Ambulatory Surgical Centers
1.4 Global Crohn’s Disease Therapeutics Market Size & Forecast
1.5 Global Crohn’s Disease Therapeutics Market Size and Forecast by Region
1.5.1 Global Crohn’s Disease Therapeutics Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Crohn’s Disease Therapeutics Market Size by Region, (2016-2021)
1.5.3 North America Crohn’s Disease Therapeutics Market Size and Prospect (2016-2026)
1.5.4 Europe Crohn’s Disease Therapeutics Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Crohn’s Disease Therapeutics Market Size and Prospect (2016-2026)
1.5.6 South America Crohn’s Disease Therapeutics Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Crohn’s Disease Therapeutics Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Crohn’s Disease Therapeutics Market Drivers
1.6.2 Crohn’s Disease Therapeutics Market Restraints
1.6.3 Crohn’s Disease Therapeutics Trends Analysis
2 Company Profiles
2.1 Johnson and Johnson Services Inc.
2.1.1 Johnson and Johnson Services Inc. Details
2.1.2 Johnson and Johnson Services Inc. Major Business
2.1.3 Johnson and Johnson Services Inc. Crohn’s Disease Therapeutics Product and Solutions
2.1.4 Johnson and Johnson Services Inc. Crohn’s Disease Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Johnson and Johnson Services Inc. Recent Developments and Future Plans
2.2 Pfizer Inc.
2.2.1 Pfizer Inc. Details
2.2.2 Pfizer Inc. Major Business
2.2.3 Pfizer Inc. Crohn’s Disease Therapeutics Product and Solutions
2.2.4 Pfizer Inc. Crohn’s Disease Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Pfizer Inc. Recent Developments and Future Plans
2.3 Allergan
2.3.1 Allergan Details
2.3.2 Allergan Major Business
2.3.3 Allergan Crohn’s Disease Therapeutics Product and Solutions
2.3.4 Allergan Crohn’s Disease Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Allergan Recent Developments and Future Plans
2.4 AbbVie Inc.
2.4.1 AbbVie Inc. Details
2.4.2 AbbVie Inc. Major Business
2.4.3 AbbVie Inc. Crohn’s Disease Therapeutics Product and Solutions
2.4.4 AbbVie Inc. Crohn’s Disease Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 AbbVie Inc. Recent Developments and Future Plans
2.5 Takeda Pharmaceutical Company Limited
2.5.1 Takeda Pharmaceutical Company Limited Details
2.5.2 Takeda Pharmaceutical Company Limited Major Business
2.5.3 Takeda Pharmaceutical Company Limited Crohn’s Disease Therapeutics Product and Solutions
2.5.4 Takeda Pharmaceutical Company Limited Crohn’s Disease Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Takeda Pharmaceutical Company Limited Recent Developments and Future Plans
2.6 Celgene Corporation
2.6.1 Celgene Corporation Details
2.6.2 Celgene Corporation Major Business
2.6.3 Celgene Corporation Crohn’s Disease Therapeutics Product and Solutions
2.6.4 Celgene Corporation Crohn’s Disease Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Celgene Corporation Recent Developments and Future Plans
2.7 Perrigo Company PLC
2.7.1 Perrigo Company PLC Details
2.7.2 Perrigo Company PLC Major Business
2.7.3 Perrigo Company PLC Crohn’s Disease Therapeutics Product and Solutions
2.7.4 Perrigo Company PLC Crohn’s Disease Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 Perrigo Company PLC Recent Developments and Future Plans
2.8 Ferring B.V.
2.8.1 Ferring B.V. Details
2.8.2 Ferring B.V. Major Business
2.8.3 Ferring B.V. Crohn’s Disease Therapeutics Product and Solutions
2.8.4 Ferring B.V. Crohn’s Disease Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 Ferring B.V. Recent Developments and Future Plans
2.9 Salix Pharmaceuticals
2.9.1 Salix Pharmaceuticals Details
2.9.2 Salix Pharmaceuticals Major Business
2.9.3 Salix Pharmaceuticals Crohn’s Disease Therapeutics Product and Solutions
2.9.4 Salix Pharmaceuticals Crohn’s Disease Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 Salix Pharmaceuticals Recent Developments and Future Plans
2.10 Gilead Sciences Inc.
2.10.1 Gilead Sciences Inc. Details
2.10.2 Gilead Sciences Inc. Major Business
2.10.3 Gilead Sciences Inc. Crohn’s Disease Therapeutics Product and Solutions
2.10.4 Gilead Sciences Inc. Crohn’s Disease Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
2.10.5 Gilead Sciences Inc. Recent Developments and Future Plans
2.11 Genentech Inc.
2.11.1 Genentech Inc. Details
2.11.2 Genentech Inc. Major Business
2.11.3 Genentech Inc. Crohn’s Disease Therapeutics Product and Solutions
2.11.4 Genentech Inc. Crohn’s Disease Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
2.11.5 Genentech Inc. Recent Developments and Future Plans
2.12 UCB India Private Limited.
2.12.1 UCB India Private Limited. Details
2.12.2 UCB India Private Limited. Major Business
2.12.3 UCB India Private Limited. Crohn’s Disease Therapeutics Product and Solutions
2.12.4 UCB India Private Limited. Crohn’s Disease Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
2.12.5 UCB India Private Limited. Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Crohn’s Disease Therapeutics Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 5 Crohn’s Disease Therapeutics Players Market Share
3.2.2 Top 10 Crohn’s Disease Therapeutics Players Market Share
3.2.3 Market Competition Trend
3.3 Crohn’s Disease Therapeutics Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Crohn’s Disease Therapeutics Revenue and Market Share by Type (2016-2021)
4.2 Global Crohn’s Disease Therapeutics Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Crohn’s Disease Therapeutics Revenue Market Share by Application (2016-2021)
5.2 Crohn’s Disease Therapeutics Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Crohn’s Disease Therapeutics Revenue by Type (2016-2026)
6.2 North America Crohn’s Disease Therapeutics Revenue by Application (2016-2026)
6.3 North America Crohn’s Disease Therapeutics Market Size by Country
6.3.1 North America Crohn’s Disease Therapeutics Revenue by Country (2016-2026)
6.3.2 United States Crohn’s Disease Therapeutics Market Size and Forecast (2016-2026)
6.3.3 Canada Crohn’s Disease Therapeutics Market Size and Forecast (2016-2026)
6.3.4 Mexico Crohn’s Disease Therapeutics Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Crohn’s Disease Therapeutics Revenue by Type (2016-2026)
7.2 Europe Crohn’s Disease Therapeutics Revenue by Application (2016-2026)
7.3 Europe Crohn’s Disease Therapeutics Market Size by Country
7.3.1 Europe Crohn’s Disease Therapeutics Revenue by Country (2016-2026)
7.3.2 Germany Crohn’s Disease Therapeutics Market Size and Forecast (2016-2026)
7.3.3 France Crohn’s Disease Therapeutics Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Crohn’s Disease Therapeutics Market Size and Forecast (2016-2026)
7.3.5 Russia Crohn’s Disease Therapeutics Market Size and Forecast (2016-2026)
7.3.6 Italy Crohn’s Disease Therapeutics Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Crohn’s Disease Therapeutics Revenue by Type (2016-2026)
8.2 Asia-Pacific Crohn’s Disease Therapeutics Revenue by Application (2016-2026)
8.3 Asia-Pacific Crohn’s Disease Therapeutics Market Size by Region
8.3.1 Asia-Pacific Crohn’s Disease Therapeutics Revenue by Region (2016-2026)
8.3.2 China Crohn’s Disease Therapeutics Market Size and Forecast (2016-2026)
8.3.3 Japan Crohn’s Disease Therapeutics Market Size and Forecast (2016-2026)
8.3.4 South Korea Crohn’s Disease Therapeutics Market Size and Forecast (2016-2026)
8.3.5 India Crohn’s Disease Therapeutics Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Crohn’s Disease Therapeutics Market Size and Forecast (2016-2026)
8.3.7 Australia Crohn’s Disease Therapeutics Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Crohn’s Disease Therapeutics Revenue by Type (2016-2026)
9.2 South America Crohn’s Disease Therapeutics Revenue by Application (2016-2026)
9.3 South America Crohn’s Disease Therapeutics Market Size by Country
9.3.1 South America Crohn’s Disease Therapeutics Revenue by Country (2016-2026)
9.3.2 Brazil Crohn’s Disease Therapeutics Market Size and Forecast (2016-2026)
9.3.3 Argentina Crohn’s Disease Therapeutics Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Crohn’s Disease Therapeutics Revenue by Type (2016-2026)
10.2 Middle East & Africa Crohn’s Disease Therapeutics Revenue by Application (2016-2026)
10.3 Middle East & Africa Crohn’s Disease Therapeutics Market Size by Country
10.3.1 Middle East & Africa Crohn’s Disease Therapeutics Revenue by Country (2016-2026)
10.3.2 Turkey Crohn’s Disease Therapeutics Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Crohn’s Disease Therapeutics Market Size and Forecast (2016-2026)
10.3.4 UAE Crohn’s Disease Therapeutics Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
Table 1. Global Crohn’s Disease Therapeutics Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Crohn’s Disease Therapeutics Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Crohn’s Disease Therapeutics Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Crohn’s Disease Therapeutics Revenue (USD Million) by Region (2016-2021)
Table 5. Global Crohn’s Disease Therapeutics Revenue Market Share by Region (2021-2026)
Table 6. Johnson and Johnson Services Inc. Corporate Information, Head Office, and Major Competitors
Table 7. Johnson and Johnson Services Inc. Major Business
Table 8. Johnson and Johnson Services Inc. Crohn’s Disease Therapeutics Product and Solutions
Table 9. Johnson and Johnson Services Inc. Crohn’s Disease Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Pfizer Inc. Corporate Information, Head Office, and Major Competitors
Table 11. Pfizer Inc. Major Business
Table 12. Pfizer Inc. Crohn’s Disease Therapeutics Product and Solutions
Table 13. Pfizer Inc. Crohn’s Disease Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Allergan Corporate Information, Head Office, and Major Competitors
Table 15. Allergan Major Business
Table 16. Allergan Crohn’s Disease Therapeutics Product and Solutions
Table 17. Allergan Crohn’s Disease Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. AbbVie Inc. Corporate Information, Head Office, and Major Competitors
Table 19. AbbVie Inc. Major Business
Table 20. AbbVie Inc. Crohn’s Disease Therapeutics Product and Solutions
Table 21. AbbVie Inc. Crohn’s Disease Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Takeda Pharmaceutical Company Limited Corporate Information, Head Office, and Major Competitors
Table 23. Takeda Pharmaceutical Company Limited Major Business
Table 24. Takeda Pharmaceutical Company Limited Crohn’s Disease Therapeutics Product and Solutions
Table 25. Takeda Pharmaceutical Company Limited Crohn’s Disease Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Celgene Corporation Corporate Information, Head Office, and Major Competitors
Table 27. Celgene Corporation Major Business
Table 28. Celgene Corporation Crohn’s Disease Therapeutics Product and Solutions
Table 29. Celgene Corporation Crohn’s Disease Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. Perrigo Company PLC Corporate Information, Head Office, and Major Competitors
Table 31. Perrigo Company PLC Major Business
Table 32. Perrigo Company PLC Crohn’s Disease Therapeutics Product and Solutions
Table 33. Perrigo Company PLC Crohn’s Disease Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. Ferring B.V. Corporate Information, Head Office, and Major Competitors
Table 35. Ferring B.V. Major Business
Table 36. Ferring B.V. Crohn’s Disease Therapeutics Product and Solutions
Table 37. Ferring B.V. Crohn’s Disease Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. Salix Pharmaceuticals Corporate Information, Head Office, and Major Competitors
Table 39. Salix Pharmaceuticals Major Business
Table 40. Salix Pharmaceuticals Crohn’s Disease Therapeutics Product and Solutions
Table 41. Salix Pharmaceuticals Crohn’s Disease Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 42. Gilead Sciences Inc. Corporate Information, Head Office, and Major Competitors
Table 43. Gilead Sciences Inc. Major Business
Table 44. Gilead Sciences Inc. Crohn’s Disease Therapeutics Product and Solutions
Table 45. Gilead Sciences Inc. Crohn’s Disease Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 46. Genentech Inc. Corporate Information, Head Office, and Major Competitors
Table 47. Genentech Inc. Major Business
Table 48. Genentech Inc. Crohn’s Disease Therapeutics Product and Solutions
Table 49. Genentech Inc. Crohn’s Disease Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 50. UCB India Private Limited. Corporate Information, Head Office, and Major Competitors
Table 51. UCB India Private Limited. Major Business
Table 52. UCB India Private Limited. Crohn’s Disease Therapeutics Product and Solutions
Table 53. UCB India Private Limited. Crohn’s Disease Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 54. Global Crohn’s Disease Therapeutics Revenue (USD Million) by Players (2019-2021)
Table 55. Global Crohn’s Disease Therapeutics Revenue Share by Players (2019-2021)
Table 56. Breakdown of Crohn’s Disease Therapeutics by Company Type (Tier 1, Tier 2 and Tier 3)
Table 57. Crohn’s Disease Therapeutics Players Head Office, Products and Services Provided
Table 58. Crohn’s Disease Therapeutics Mergers & Acquisitions in the Past Five Years
Table 59. Crohn’s Disease Therapeutics New Entrants and Expansion Plans
Table 60. Global Crohn’s Disease Therapeutics Revenue (USD Million) by Type (2016-2021)
Table 61. Global Crohn’s Disease Therapeutics Revenue Share by Type (2016-2021)
Table 62. Global Crohn’s Disease Therapeutics Revenue Forecast by Type (2021-2026)
Table 63. Global Crohn’s Disease Therapeutics Revenue by Application (2016-2021)
Table 64. Global Crohn’s Disease Therapeutics Revenue Forecast by Application (2021-2026)
Table 65. North America Crohn’s Disease Therapeutics Revenue by Type (2016-2021) & (USD Million)
Table 66. North America Crohn’s Disease Therapeutics Revenue by Type (2021-2026) & (USD Million)
Table 67. North America Crohn’s Disease Therapeutics Revenue by Application (2016-2021) & (USD Million)
Table 68. North America Crohn’s Disease Therapeutics Revenue by Application (2021-2026) & (USD Million)
Table 69. North America Crohn’s Disease Therapeutics Revenue by Country (2016-2021) & (USD Million)
Table 70. North America Crohn’s Disease Therapeutics Revenue by Country (2021-2026) & (USD Million)
Table 71. Europe Crohn’s Disease Therapeutics Revenue by Type (2016-2021) & (USD Million)
Table 72. Europe Crohn’s Disease Therapeutics Revenue by Type (2021-2026) & (USD Million)
Table 73. Europe Crohn’s Disease Therapeutics Revenue by Application (2016-2021) & (USD Million)
Table 74. Europe Crohn’s Disease Therapeutics Revenue by Application (2021-2026) & (USD Million)
Table 75. Europe Crohn’s Disease Therapeutics Revenue by Country (2016-2021) & (USD Million)
Table 76. Europe Crohn’s Disease Therapeutics Revenue by Country (2021-2026) & (USD Million)
Table 77. Asia-Pacific Crohn’s Disease Therapeutics Revenue by Type (2016-2021) & (USD Million)
Table 78. Asia-Pacific Crohn’s Disease Therapeutics Revenue by Type (2021-2026) & (USD Million)
Table 79. Asia-Pacific Crohn’s Disease Therapeutics Revenue by Application (2016-2021) & (USD Million)
Table 80. Asia-Pacific Crohn’s Disease Therapeutics Revenue by Application (2021-2026) & (USD Million)
Table 81. Asia-Pacific Crohn’s Disease Therapeutics Revenue by Region (2016-2021) & (USD Million)
Table 82. Asia-Pacific Crohn’s Disease Therapeutics Revenue by Region (2021-2026) & (USD Million)
Table 83. South America Crohn’s Disease Therapeutics Revenue by Type (2016-2021) & (USD Million)
Table 84. South America Crohn’s Disease Therapeutics Revenue by Type (2021-2026) & (USD Million)
Table 85. South America Crohn’s Disease Therapeutics Revenue by Application (2016-2021) & (USD Million)
Table 86. South America Crohn’s Disease Therapeutics Revenue by Application (2021-2026) & (USD Million)
Table 87. South America Crohn’s Disease Therapeutics Revenue by Country (2016-2021) & (USD Million)
Table 88. South America Crohn’s Disease Therapeutics Revenue by Country (2021-2026) & (USD Million)
Table 89. Middle East & Africa Crohn’s Disease Therapeutics Revenue by Type (2016-2021) & (USD Million)
Table 90. Middle East & Africa Crohn’s Disease Therapeutics Revenue by Type (2021-2026) & (USD Million)
Table 91. Middle East & Africa Crohn’s Disease Therapeutics Revenue by Application (2016-2021) & (USD Million)
Table 92. Middle East & Africa Crohn’s Disease Therapeutics Revenue by Application (2021-2026) & (USD Million)
Table 93. Middle East & Africa Crohn’s Disease Therapeutics Revenue by Country (2016-2021) & (USD Million)
Table 94. Middle East & Africa Crohn’s Disease Therapeutics Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Crohn’s Disease Therapeutics Picture
Figure 2. Global Crohn’s Disease Therapeutics Revenue Market Share by Type in 2020
Figure 3. Non-Surgical
Figure 4. Surgical
Figure 5. Crohn’s Disease Therapeutics Revenue Market Share by Application in 2020
Figure 6. Hospitals Picture
Figure 7. Ambulatory Surgical Centers Picture
Figure 8. Global Crohn’s Disease Therapeutics Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 9. Global Crohn’s Disease Therapeutics Revenue and Forecast (2016-2026) & (USD Million)
Figure 10. Global Crohn’s Disease Therapeutics Revenue Market Share by Region (2016-2026)
Figure 11. Global Crohn’s Disease Therapeutics Revenue Market Share by Region in 2020
Figure 12. North America Crohn’s Disease Therapeutics Revenue (USD Million) and Growth Rate (2016-2026)
Figure 13. Europe Crohn’s Disease Therapeutics Revenue (USD Million) and Growth Rate (2016-2026)
Figure 14. Asia-Pacific Crohn’s Disease Therapeutics Revenue (USD Million) and Growth Rate (2016-2026)
Figure 15. South America Crohn’s Disease Therapeutics Revenue (USD Million) and Growth Rate (2016-2026)
Figure 16. Crohn’s Disease Therapeutics Market Drivers
Figure 17. Crohn’s Disease Therapeutics Market Restraints
Figure 18. Crohn’s Disease Therapeutics Market Trends
Figure 19. Johnson and Johnson Services Inc. Recent Developments and Future Plans
Figure 20. Pfizer Inc. Recent Developments and Future Plans
Figure 21. Allergan Recent Developments and Future Plans
Figure 22. AbbVie Inc. Recent Developments and Future Plans
Figure 23. Takeda Pharmaceutical Company Limited Recent Developments and Future Plans
Figure 24. Celgene Corporation Recent Developments and Future Plans
Figure 25. Perrigo Company PLC Recent Developments and Future Plans
Figure 26. Ferring B.V. Recent Developments and Future Plans
Figure 27. Salix Pharmaceuticals Recent Developments and Future Plans
Figure 28. Gilead Sciences Inc. Recent Developments and Future Plans
Figure 29. Genentech Inc. Recent Developments and Future Plans
Figure 30. UCB India Private Limited. Recent Developments and Future Plans
Figure 32. Global Crohn’s Disease Therapeutics Revenue Share by Players in 2020
Figure 33. Crohn’s Disease Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 34. Global Top 3 Players Crohn’s Disease Therapeutics Revenue Market Share in 2020
Figure 35. Global Top 10 Players Crohn’s Disease Therapeutics Revenue Market Share in 2020
Figure 36. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 37. Global Crohn’s Disease Therapeutics Revenue Share by Type in 2020
Figure 38. Global Crohn’s Disease Therapeutics Market Share Forecast by Type (2021-2026)
Figure 39. Global Crohn’s Disease Therapeutics Revenue Share by Application in 2020
Figure 40. Global Crohn’s Disease Therapeutics Market Share Forecast by Application (2021-2026)
Figure 41. North America Crohn’s Disease Therapeutics Sales Market Share by Type (2016-2026)
Figure 42. North America Crohn’s Disease Therapeutics Sales Market Share by Application (2016-2026)
Figure 43. North America Crohn’s Disease Therapeutics Revenue Market Share by Country (2016-2026)
Figure 44. United States Crohn’s Disease Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 45. Canada Crohn’s Disease Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 46. Mexico Crohn’s Disease Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 47. Europe Crohn’s Disease Therapeutics Sales Market Share by Type (2016-2026)
Figure 48. Europe Crohn’s Disease Therapeutics Sales Market Share by Application (2016-2026)
Figure 49. Europe Crohn’s Disease Therapeutics Revenue Market Share by Country (2016-2026)
Figure 50. Germany Crohn’s Disease Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. France Crohn’s Disease Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. United Kingdom Crohn’s Disease Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. Russia Crohn’s Disease Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. Italy Crohn’s Disease Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. Asia-Pacific Crohn’s Disease Therapeutics Sales Market Share by Type (2016-2026)
Figure 56. Asia-Pacific Crohn’s Disease Therapeutics Sales Market Share by Application (2016-2026)
Figure 57. Asia-Pacific Crohn’s Disease Therapeutics Revenue Market Share by Region (2016-2026)
Figure 58. China Crohn’s Disease Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. Japan Crohn’s Disease Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. South Korea Crohn’s Disease Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. India Crohn’s Disease Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. Southeast Asia Crohn’s Disease Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. Australia Crohn’s Disease Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. South America Crohn’s Disease Therapeutics Sales Market Share by Type (2016-2026)
Figure 65. South America Crohn’s Disease Therapeutics Sales Market Share by Application (2016-2026)
Figure 66. South America Crohn’s Disease Therapeutics Revenue Market Share by Country (2016-2026)
Figure 67. Brazil Crohn’s Disease Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. Argentina Crohn’s Disease Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 69. Middle East and Africa Crohn’s Disease Therapeutics Sales Market Share by Type (2016-2026)
Figure 70. Middle East and Africa Crohn’s Disease Therapeutics Sales Market Share by Application (2016-2026)
Figure 71. Middle East and Africa Crohn’s Disease Therapeutics Revenue Market Share by Country (2016-2026)
Figure 72. Turkey Crohn’s Disease Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 73. Saudi Arabia Crohn’s Disease Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. UAE Crohn’s Disease Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. Methodology
Figure 76. Research Process and Data Source
世界のクローン病市場規模・現状・予測（2021年-2027年） Crohn’s disease refers to long term inflammatory bowel disease, which causes inflammation of the lining of the digestive tract. It affects the large and small intestine and is generally diagnosed in persons within the age group of 20-29. It can have severe or acute outcomes. Signs and symptoms of Cr…- 世界のクローン病診断・治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Crohn's Disease Diagnostic and Therapeutic Market The global Crohn's Disease Diagnostic and Therapeutic market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in an…
- 世界のサンドホフ病治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Sandhoff Disease Therapeutics Market The global Sandhoff Disease Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integ…
- 世界の炎症性腸疾患治療薬市場 2021：企業別、地域別、種類・用途別 The Inflammatory Bowel Disease Therapeutics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimizatio…
- 世界のアルツハイマー病治療市場規模・現状・予測（2021年-2027年） Alzheimer’s disease is a neurodegenerative, progressive, non-reversible disorder. Alzheimer’s disease is caused due to abnormal functioning of brain cells i.e. failure of synaptic transmission, resulting in the loss of cognitive functions. Some of the signs and symptoms of alzheimer’s disease are me…